$MRNA
Хорошая и общепонятна статья о том, почему. Moderna будет лететь хорошо, даже если и не очень быстро ;)
mRNA Vaccines Could Vanquish Covid Today, Cancer Tomorrow
The best news about the mRNA shots from BioNTech and Moderna is that the same technique could also defeat many other diseases.
https://www.bloomberg.com/opinion/articles/2021-01-09/pfizer-moderna-mrna-vaccines-could-vanquish-covid-today-cancer-tomorrow
1
Нравится
Не является индивидуальной инвестиционной рекомендацией
Пульс учит
Обучающие материалы об инвестициях от опытных пользователей
vasilisqve
0 подписчиков • 7 подписок
Портфель
до 10 000 ₽
Доходность
0%
Еще статьи от автора
5 мая 2021
ATRA Ну всё, ноовый прогноз наконец. Заживём.
11 февраля 2021
ATRA дневник занимательных наблюдений — а ведь в словах “атара” и “го-но” — одинаковое количество букв ;)
27 января 2021
XLNX https://investor.xilinx.com/news-releases/news-release-details/xilinx-reports-third-quarter-fiscal-year-2021-results
EPS выше прогнозов 0.78 > прогноз 0.6856, revenue 803.4 > прогноз 775.73.
===
Xilinx Reports Third Quarter Fiscal Year 2021 Results
* Revenues of $803 million exceeded the high end of guidance, representing 5% sequential and 11% year over year growth
* Wired and Wireless Group (WWG) revenue increased 14% sequentially due to strength in the Wireless markets as 5G deployments ramped in multiple regions
* Automotive, Broadcast & Consumer (ABC) revenue increased 27% sequentially, driven by record quarters in the Automotive and Broadcast end markets
* Aerospace & Defense, Industrial and Test, Measurement & Emulation (AIT) revenue increased 7% sequentially, driven by strong performance in the Test, Measurement and Emulation market
* Data Center Group (DCG) revenue declined 45% sequentially, in line with expectations, compared to a record second quarter which benefited from trade-related order acceleration
* Free cash flow of $354 million, representing 44% of revenue
* Returned $93 million to stockholders through dividends